Original language | English |
---|---|
Pages (from-to) | 6-12 |
Number of pages | 7 |
Journal | Kidney International |
Volume | 103 |
Issue number | 1 |
Early online date | 3 Jan 2023 |
DOIs | |
Publication status | Published - 3 Jan 2023 |
Bibliographical note
Funding Information:SA is funded by National Institute of Diabetes and Digestive and Kidney Diseases R01 DK127138.
Funding Information:
JB-D reports support from Centers for Disease Control and Prevention (U19 OH01127) and National Institutes of Health (R21 ES028826), and in part by Pantaleon and the Chancellor, University of Colorado, CU Anschutz Campus. The University of Colorado has a memorandum of agreement with Pantaleon, a Guatemala-based agribusiness. The terms of this arrangement have been reviewed and approved by the University of Colorado in accordance with its conflict of interest policies. BS is supported by a Jacquot Research Establishment Fellowship from the Royal Australasian College of Physicians. Funders had no role in writing the article. All the other authors declared no competing interests.
Keywords
- chronic kidney disease of unknown origin (CKDu)
- clinical trials
- intervention
- occupational health
- prevention
- study design